Literature DB >> 21951844

Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1.

Yi-Kun Zhang1, Hua Wang, Yun Leng, Ze-Liang Li, Yue-Feng Yang, Feng-Jun Xiao, Qing-Fang Li, Xie-Qun Chen, Li-Sheng Wang.   

Abstract

MicroRNAs (miRNAs) are small, noncoding ribonucleic acids (ncRNAs), which regulate gene expression by targeting mRNAs for translational repression and degradation. Several lines of evidences have indicated that miRNAs act as tumor suppressors and oncogenes. However, the role of miRNAs in pathogenesis of multiple myeloma (MM) remains unclear. In this study, we examined the profile of miRNA expression of primary MM cells, using miRNA microarray and quantitative real-time polymerase chain reaction (qPCR) techniques. These results showed that in the bone marrow specimens analyzed, miRNA-29b was significantly downregulated. Similar results were also observed in human myeloma cell lines (HMCLs). Adenovirus-mediated overexpression of miR-29b induced apoptosis and elevated caspase-3 activation in HMCLs. Using a bioinformatics approach, we found a perfect complementarity between miRNA-29b and the 3'UTR of myeloid-cell-leukemia 1(Mcl-1). It is further confirmed that miRNA-29b downregulated the level of Mcl-1 without effect on the mRNA level using both qRT-PCR assays and Western blot analyses. Moreover, we observed that enforced miR-29b expression by using a retarget miRNA-29b expression vector (Ad5F11p-miR-29b) could induce apoptosis and elevate caspase-3 activation in HMCLs. Our results also indicated that miRNA-29b-induced apoptosis acted antagonistically with IL-6 in HMCLs. These findings suggest that miRNA-29b may play an important role in MM as a tumor suppressor.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951844     DOI: 10.1016/j.bbrc.2011.09.063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  49 in total

1.  TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.

Authors:  Zaijun Lin; Dianwen Song; Haifeng Wei; Xinghai Yang; Tielong Liu; Wangjun Yan; Jianru Xiao
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-15       Impact factor: 4.553

2.  Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.

Authors:  Rebecca Kohnken; Jing Wen; Bethany Mundy-Bosse; Kathleen McConnell; Ashleigh Keiter; Leah Grinshpun; Alex Hartlage; Max Yano; Betina McNeil; Nitin Chakravarti; Basem William; James E Bradner; Michael A Caligiuri; Pierluigi Porcu; Anjali Mishra
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

3.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

4.  Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.

Authors:  Jing-jing Huang; Juan Yu; Jiang-yan Li; Yao-ting Liu; Ren-qian Zhong
Journal:  Med Oncol       Date:  2012-03-24       Impact factor: 3.064

Review 5.  MicroRNAs as regulators of bone homeostasis and bone metastasis.

Authors:  Brian Ell; Yibin Kang
Journal:  Bonekey Rep       Date:  2014-07-02

6.  Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.

Authors:  Karolina Nemes; Monika Csóka; Noémi Nagy; Ágnes Márk; Zsófia Váradi; Titanilla Dankó; Gábor Kovács; László Kopper; Anna Sebestyén
Journal:  Pathol Oncol Res       Date:  2014-11-12       Impact factor: 3.201

Review 7.  MicroRNA theragnostics for the clinical management of multiple myeloma.

Authors:  N Ahmad; S Haider; S Jagannathan; E Anaissie; J J Driscoll
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

8.  The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro.

Authors:  Qian Cheng; Xin Li; Yue Wang; Min Dong; Feng-Huang Zhan; Jing Liu
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

Review 9.  MicroRNAs in multiple myeloma and related bone disease.

Authors:  Marco Rossi; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Ann Transl Med       Date:  2015-12

Review 10.  MicroRNA and signal transduction pathways in tumor radiation response.

Authors:  Luqing Zhao; Xiongbin Lu; Ya Cao
Journal:  Cell Signal       Date:  2013-04-17       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.